IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes
AUTOR(ES)
Campos, Paula de Melo, Machado-Neto, João Agostinho, Lorand-Metze, Irene, Costa, Fernando Ferreira, Saad, Sara Teresinha Olalla, Traina, Fabiola
FONTE
Hematol., Transfus. Cell Ther.
DATA DE PUBLICAÇÃO
2018-03
RESUMO
Documentos Relacionados
- Bone marrow lymphocyte subsets in myelodysplastic syndromes.
- Sea blue histiocytosis: a common abnormality of the bone marrow in myelodysplastic syndromes.
- Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
- Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.
- Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes
